包装: | 100ug |
规格: | 98% |
市场价: | 2844元 |
分子量: | 445.9 |
Background:
Midazolam-d4(maleate) (CRM) is intended for use as an internal standard for the quantification of midazolam by GC- or LC-MS. Midazolam is used for sedation, to block seizures, and as an anticonvulsant antidote for organophosphate intoxication.1,2,3This product is intended for research and forensic applications.
1.Kiriyama, S., Naitoh, H., and Kuwano, H.Propofol sedation during endoscopic treatment for early gastric cancer compared to midazolamWorld J. Gastroenterol.20(34)11985-11990(2014) 2.Mazurkiewicz-Be?dzińska, M., Szmuda, M., Zawadzka, M., et al.Current treatment of convulsive status epilepticus - a therapeutic protocol and reviewAnaesthesiol.Intensive Ther.46(4)293-300(2014) 3.Reddy, S.D., and Reddy, D.S.Midazolam as an anticonvulsant antidote for organophosphate intoxication--a pharmacotherapeutic appraisalEpilepsia56(6)813-821(2015)